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Objectives. We sought to examine the relation between regional
changes in intramyocardial function and global left ventricular
(LV) remodeling in the first 8 weeks after reperfused first anterior
myocardial infarction (MI).
Background. Because of limitations in imaging methods used to
date, this relation has not been thoroughly evaluated.
Methods. We studied 26 patients (21 men, 5 women; mean age
51 years) by magnetic resonance imaging (MRI) on day 5 6 2
(mean 6 SD) and week 8 6 1 after their first anterior MI. All
patients had single-vessel left anterior descending coronary artery
disease and although they had received reperfusion therapy, all
had regional LV dysfunction and an initial ejection fraction (EF)
<250%. Short-axis magnetic resonance tagging was performed
spanning the LV. Percent intramyocardial circumferential short-
ening (%S) on a topographic basis, LV mass index, LV end-
diastolic volume index (LVEDVI), LV end-systolic volume index
and LV ejection fraction (LVEF) were measured.
Results. Left ventricular mass index tended to decrease,
whereas the LVEDVI increased from 82 6 24 to 96 6 27 ml/m2
(p 5 0.002). Left ventricular end-systolic volume index remained
unchanged, whereas LVEF increased from 39 6 12% to 45 6 14%
(p 5 0.002). Apical %S improved from 9 6 6% to 13 6 5% (p <
0.0001), as it did in the midanterior (6 6 6% to 10 6 7%, p < 0.02)
and midseptal regions (8 6 7% to 12 6 6%, p < 0.02). Early
dysfunction in remote midinferior and basal lateral regions
resolved by 8 weeks. By multivariate analysis, the only significant
predictor of an increase in LVEDVI over the study period was
peak creatine kinase (p 5 0.04).
Conclusions. In the first 8 weeks after a large, reperfused
anterior MI, %S improved in the apex, midanterior and midseptal
regions and normalized in remote noninfarct-related regions, but
LV end-diastolic volumes also increased. This increased LVEDVI
correlated with infarct size by peak creatine kinase and was not
related to changes in global and regional LV function.
(J Am Coll Cardiol 1997;30:1625–32)
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The hallmark of left ventricular (LV) remodeling after myo-
cardial infarction (MI) is LV dilation (1,2). The initial event is
expansion of the infarct-related segment (3,4) due to cell
slippage (5), followed by lengthening of noninfarct-related
segments (6,7) due to cell slippage and cellular hypertrophy
(8,9). The natural history of regional intramyocardial function
in the chronic phase after nonreperfused MI has been studied
in an ovine model (7) using magnetic resonance tagging
(10,11). In this model, LV dilation and hypertrophy progress
despite an improvement in function in regions adjacent to the
infarct-related segment over time. In humans, we have recently
demonstrated dysfunction in remote noninfarct-related re-
gions early after reperfused anterior MI using magnetic reso-
nance tagging (12). The relation between changes in intramyo-
cardial function over time and changes in LV volumes and
mass in humans is not fully understood.
The end result of LV remodeling is an increase in end-
diastolic and end-systolic volumes, which is predictive of
increased mortality after MI (13). In the past decade, therapies
to limit LV remodeling have been developed(14) and demon-
strated to limit mortality after large MI with LV dysfunction
(15–17). We wished to examine the relation between intramyo-
cardial function and LV remodeling after anterior MI in this
era to better understand correlates of the remodeling process.
Methods
Patient group. This study was approved by the Institutional
Review Board of Allegheny General Hospital, and all human
subjects gave written informed consent. Ten normal subjects,
including seven men and three women (mean age 42 6 15
years), underwent magnetic resonance imaging (MRI). None
had clinical or echocardiographic evidence of cardiac disease.
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We initially studied 32 patients after their first anterior MI. All
had left anterior descending coronary artery (LAD) single-
vessel disease without significant ($50%) disease in the other
major epicardial coronary arteries. The diagnosis of MI was
made in the conventional manner using clinical history, elec-
trocardiography and plasma creatine kinase levels, drawn every
8 h and elevated to more than twice the normal level with an
MB fraction .5%.
All patients were studied by MRI on day 5 6 2 after MI.
One patient died suddenly at home on day 10 after MI; two
patients underwent single-vessel coronary artery bypass graft
surgery within the first few weeks after MI for significant
proximal LAD disease; and three patients did not return for
follow-up. The remaining 26 patients returned for repeat MRI
at 8 6 1 weeks after MI and comprise the study group (Table
1).
The average age of the 26 patients was 51 6 12 years; 21
were men and 5 were women. Three were treated with
thrombolysis alone, 16 with primary angioplasty and 7 with
rescue angioplasty after failed thrombolytic therapy. The av-
erage time to reperfusion in the 23 patients for which this
variable was known was 307 6 166 min. The peak creatine
kinase level was 2,861 6 1,917 U/liter. By electrocardiography,
21 patients had Q wave and 5 had non–Q wave infarctions. All
had evidence of regional LV dysfunction and an LV ejection
fraction (LVEF) #50% by left ventriculography or echocardi-
ography before entry into the study. The mean LVEF by these
imaging techniques was 38 6 8%. All had a documented
patent infarct-related artery and Thrombolysis in Myocardial
Infarction flow grade 3 by X-ray angiography before the initial
study. The patients’ medications between day 5 and week 8
included aspirin in 21 patients, angiotensin-converting enzyme
(ACE) inhibitors in 21, beta-blockers in 17, Coumadin in 15,
nitrates in 4, digoxin in 3, lasix in 1 and a calcium channel
blocker in 1.
Abbreviations and Acronyms
ACE 5 angiotensin-converting enzyme
LAD 5 left anterior descending coronary artery
LV 5 left ventricle, left ventricular
LVEDVI 5 left ventricular end-diastolic volume index
LVEF 5 left ventricular ejection fraction
LVESVI 5 left ventricular end-systolic volume index
LVMI 5 left ventricular mass index
MI 5 myocardial infarction
MRI 5 magnetic resonance imaging
%S 5 percent intramyocardial circumferential shortening
Table 1. Clinical Variables in the 26 Study Patients
Pt No./
Gender
Age
(yr) Rx
Time to Rx
(min)
Peak CK
(U/liter)
First MRI Second MRI
ACE Beta-Blocker Nitrates
HR
(beats/min)
BP
(mm Hg)
HR
(beats/min)
BP
(mm Hg)
1/M 42 t-PA/PTCA 270 1,300 100 134/80 92 128/74 Y Y N
2/M 37 PTCA N/A 4,310 86 110/70 60 96/60 Y Y N
3/M 72 t-PA/PTCA 335 2,370 68 112/64 68 100/60 Y Y N
4/M 53 t-PA/PTCA 85 7,470 78 100/66 76 90/60 Y N N
5/M 46 PTCA 225 3,870 87 100/70 67 100/72 Y N Y
6/F 53 PTCA 658 1,426 63 96/60 70 Y N N
7/M 78 t-PA/PTCA 195 1,208 76 130/70 56 150/76 Y Y N
8/M 51 PTCA 90 2,185 68 98/60 56 110/70 N Y Y
9/M 43 t-PA 90 4,932 84 110/70 67 118/70 Y N N
10/M 65 PTCA 178 3,580 63 110/60 60 120/64 Y N N
11/F 61 t-PA 360 4,925 115 119/79 125 130/90 Y Y N
12/M 57 PTCA 255 1,894 68 102/63 64 147/88 Y Y N
13/M 33 PTCA 215 5,505 75 125/76 80 110/66 N Y N
14/M 63 t-PA N/A 2,838 81 98/60 77 118/78 Y Y Y
15/M 52 PTCA 200 1,137 71 138/78 57 123/73 Y Y N
16/M 44 t-PA/PTCA 450 2,123 103 107/67 80 110/70 Y Y N
17/M 45 PTCA 189 4,080 83 111/74 73 106/70 Y N N
18/M 60 PTCA 280 2,385 94 105/63 94 100/80 Y N Y
19/M 53 PTCA 580 1,845 66 93/64 63 101/79 Y N N
20/F 56 PTCA 185 963 81 91/51 61 91/59 N Y N
21/M 39 t-PA/PTCA 410 6,770 83 100/64 64 102/34 Y N N
22/M 64 PTCA 93 2,404 72 132/84 84 116/73 Y Y N
23/M 36 PTCA 471 426 79 124/67 51 124/67 N Y N
24/F 45 PTCA 418 909 77 105/65 100 160/109 Y Y N
25/M 38 t-PA/PTCA 220 3,940 75 102/61 66 127/70 Y Y N
26/F 48 PTCA 122 1,211 62 102/69 51 145/101 N Y N
ACE 5 angiotensin-converting enzyme inhibitor; BP 5 blood pressure; CK 5 creatine kinase; F 5 female; HR 5 heart rate; M 5 male; MRI 5 magnetic resonance
image; N 5 no; N/A 5 not available; Pt 5 patient; PTCA 5 percutaneous transluminal coronary angioplasty; Rx 5 treatment; t-PA 5 tissue-type plasminogen activator;
Y 5 yes.
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MRI. MRI was performed with a Siemens Magnetom SP
1.5-T scanner with the patient prone on an elliptical spine
surface coil with electrocardiographic monitoring and gating.
The imaging protocol has been well described previously (12).
Briefly, localizing scout images were followed by a single
short-axis cine series in a plane near the mitral valve, which
provided images every 40 ms to identify end-systole as the
point of minimal LV cavity area. Then a series of short-axis,
single-slice, multiple cardiac phase, tagged images were ob-
tained using a breath-hold, gradient echo method with a
segmented k-space acquisition. Tag stripe separation was
7 mm; field of view was 280 mm; and matrix size was 128 3 256,
interpolated to 256 3 256 for display, yielding a pixel size of
1.09 3 1.09 mm. Repetition time (TR), which determined the
temporal resolution, was adjusted (from a minimum of 58 ms
to a maximum of 90 ms) so as to time one image of the
five-phase image series at end-systole (always either the fourth
or fifth image). Each breath-hold spanned 18 heartbeats or 14
to 15 s/breath-hold at the average heart rate of the patients
during the two studies. Seven-millimeter thick, contiguous
image planes or slices were generated (Fig. 1), enough to span
the entire LV cavity from base to apex. The entire imaging
session lasted ;45 min. The identical imaging protocol was
performed for the 8-week post-MI study. The same number of
slices, on average, were acquired in the two studies (n 5 12 6
1 for both).
Data analysis. Quantitative analysis of images was per-
formed by a single investigator (T.M.T.) who had no knowl-
edge of the clinical information, using an operator-driven
image analysis tool developed in the “Volumetric Image
Display and Analysis” software package (VIDA, University of
Iowa) loaded on a Sun workstation. Left ventricular mass was
calculated from planimetered epicardial and endocardial areas
of interleaved short-axis end-diastolic images according to
previously published techniques (7,12) and was indexed to
body surface area. Left ventricular end-diastolic volume index
(LVEDVI), left ventricular end-systolic volume index
(LVESVI) and LVEF were calculated using planimetered
end-diastolic and end-systolic areas in the same manner.
Quantitative analysis of shortening was performed using an
operator-driven, interstripe-distance measuring software tool
developed in VIDA, as well as previously published methods
(7,12). Percent intramyocardial circumferential shortening
(%S) was measured at endocardial, mid-wall and epicardial
sites in the anterior, lateral, septal and inferior regions in the
LV short-axis in all of the slices from apex to base in each
study. The total number of slices along the long axis of the
ventricle was divided into apical, midventricular and basal
thirds (four slices each on average), and data from these slices
were averaged. A total of 12 LV regions were thereby evalu-
ated.
Statistical methods. Clinical variables, including heart
rate, blood pressure, left ventricular mass index (LVMI),
LVEDVI, LVESVI, LVEF and regional %S were compared
between the day 5 and week 8 studies by the Student paired t
test. Regional %S was compared in patients on day 5 and at
week 8 after MI with that of normal subjects using unpaired t
test. Stepwise multivariate regression analysis was performed
to assess correlates of the increase in LVEDVI from day 5 to
week 8 and the increase in LVEF during the same period.
Figure 1. A, End-systolic apical magnetic resonance-tagged short-axis
image in a patient on day 4 after anterior MI. The right ventricular
apex and interventricular septum are in the 6 to 9 o’clock position on
the image; the anterior wall from 9 to 12 o’clock; the lateral wall from
12 to 3 o’clock; and the inferior wall from 3 to 6 o’clock. Reduced
deformation of the tag stripes is seen in the anterior wall and septum
relative to the lateral and inferior regions. B, End-systolic apical
magnetic resonance-tagged short-axis image in the same patient, now
8 weeks after anterior MI. The image orientation and apex to base
position are the same as in A. Note the thinning of the anterior wall
and septum, the continued lack of deformation in those regions and
the preserved deformation in the lateral and inferior walls. The
end-systolic LV cavity area is clearly larger here than on the day 4
image.
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Variables included in the analysis were age, gender, time to
reperfusion, peak creatine kinase, LVMI, LVEDVI and
LVESVI on day 5; %S at the LV apex and %S at the LV base
on day 5; endocardial %S throughout the heart on day 5; ACE
inhibitor therapy; and beta-blocker therapy. All results are
expressed as mean value 6 SD. A p value ,0.05 was consid-
ered statistically significant.
Results
Clinical findings. The patients’ heart rate during MRI on
day 5 after MI was 80 6 13 beats/min, and their systolic and
diastolic blood pressures were 110 6 14 mm Hg and 68 6
7 mm Hg, respectively. During MRI at week 8 after MI, the
average heart rate was 73 6 17 beats/min (p , 0.02 vs. week 1),
whereas the average blood pressures were not significantly
different (systolic 118 6 20 mm Hg, p 5 0.07; diastolic 73 6
16 mm Hg, p 5 0.14).
LV global variables. The LVMI tended to decrease during
the 8-week period, falling from 109 6 19 to 102 6 18 g/m2 (p 5
0.075). The LVEDVI increased from 83 6 24 to 96 6 27 ml/m2
(p 5 0.002) (Fig. 2), whereas the LVESVI did not change
(52 6 20 ml/m2 on day 5 to 54 6 24 ml/m2 at week 8, p 5 0.42).
LVEF increased during this period from 39 6 12% to 45 6
14% (p 5 0.002). Therefore, despite a significant increase in
LVEDVI, global LV function improved in the 8-week post-MI
period.
Regional intramyocardial function. Percent S in the 12
regions around the LV from the MRI studies in the normal
subjects and in the patients on day 5 and at week 8 after MI is
shown in Table 2. When data from the three transmural levels
were averaged (Table 2, Fig. 3), a significant improvement in
%S was seen throughout all regions within the apex, as apical
anterior %S improved from 4 6 6% to 7 6 8% (p , 0.04),
apical septal %S increased from 4 6 6% to 8 6 6% (p 5
0.002), apical inferior %S increased from 14 6 10% to 18 6
9% (p 5 0.004) and apical lateral %S increased from 15 6 9%
to 18 6 8% (p , 0.04). Other regions that demonstrated
improvement included the midseptum from 8 6 7% to 12 6
Figure 2. Graph demonstrating the change in LVEDVI from the day
5 to week 8 study in each of the 26 patients. Large open squares 5
mean value.
Table 2. Regional Intramyocardial Percent Circumferential
Shortening in Normal Subjects and in Patients at Day 5 and Week 8
After Anterior Myocardial Infarction
Endocardial Mid Epicardial Average
Apex
Anterior
Normal 24 6 5 23 6 4 19 6 6 22 6 4
Day 5 7 6 9* 3 6 7* 2 6 5* 4 6 6*
Week 8 8 6 10* 7 6 8* 6 6 7*† 7 6 8*†
Septum
Normal 28 6 4 22 6 4 17 6 4 23 6 3
Day 5 5 6 7* 4 6 6* 3 6 8* 4 6 6*
Week 8 11 6 7*† 7 6 6*† 7 6 7*† 8 6 6*†
Inferior
Normal 24 6 8 22 6 5 18 6 5 21 6 5
Day 5 16 6 10* 13 6 9* 13 6 10* 14 6 10*
Week 8 21 6 8† 17 6 9*† 15 6 10 18 6 9†
Lateral
Normal 35 6 4 27 6 6 23 6 4 28 6 4
Day 5 16 6 9* 15 6 9* 17 6 8* 15 6 9*
Week 8 19 6 10* 18 6 8* 13 6 9* 18 6 8*†
Mid
Anterior
Normal 22 6 12 20 6 5 14 6 4 18 6 6
Day 5 9 6 7* 5 6 7* 5 6 5* 6 6 6*
Week 8 12 6 9*† 9 6 8*† 9 6 8*† 10 6 7*†
Septum
Normal 25 6 4 22 6 6 16 6 5 21 6 4
Day 5 10 6 8* 8 6 9* 7 6 7* 8 6 7*
Week 8 14 6 8*† 11 6 8* 9 6 7* 12 6 6*†
Inferior
Normal 25 6 5 20 6 5 17 6 4 21 6 4
Day 5 17 6 14* 15 6 11 13 6 12 15 6 11*
Week 8 21 6 7 17 6 7 15 6 7 18 6 6
Lateral
Normal 31 6 5 26 6 5 23 6 5 27 6 2
Day 5 17 6 9* 18 6 7* 13 6 6* 16 6 7*
Week 8 19 6 9* 20 6 8* 16 6 7*† 18 6 7*
Base
Anterior
Normal 19 6 4 16 6 3 13 6 5 16 6 3
Day 5 14 6 8* 10 6 7* 7 6 8* 11 6 6*
Week 8 15 6 8 12 6 6* 10 6 7 13 6 6*
Septum
Normal 23 6 3 20 6 4 16 6 5 19 6 4
Day 5 18 6 9* 13 6 8* 13 6 8* 15 6 7*
Week 8 18 6 9* 14 6 4* 11 6 5* 14 6 4*
Inferior
Normal 22 6 6 17 6 4 13 6 7 17 6 5
Day 5 21 6 9 19 6 8 16 6 7 19 6 8
Week 8 21 6 8 19 6 6 16 6 5 19 6 6
Lateral
Normal 27 6 7 21 6 9 19 6 9 23 6 7
Day 5 22 6 7* 19 6 6 14 6 8 18 6 5*
Week 8 24 6 7 21 6 6 18 6 5† 21 6 5†
*p , 0.05 versus normal subjects. †p , 0.05 versus day 5. Data presented are
mean value 6 SD.
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6% (p , 0.02), the midanterior wall from 6 6 6% to 10 6 7%
(p , 0.02) and the basal lateral wall from 18 6 5% to 21 6 5%
(p , 0.05).
Resolution of dysfunction in patients as compared with
normal subjects from day 5 to week 8 was seen in the apical
inferior, midinferior and basal lateral regions (Table 2). The
last two regions are remote from infarct-related territory (12).
When data from all three transmural locations and four
sites around the short axis were averaged, significant improve-
ment was noted in the apex and midventricle over the 8-week
period after MI. Apical %S improved from 9 6 6% to 13 6 5%
(p , 0.0001) and midventricular %S from 11 6 5% to 14 6 5%
(p 5 0.001), although %S in both regions in patients remained
less than that in normal subjects (24 6 3% and 22 6 3%,
respectively, p , 0.001). No significant increase was found in
basal %S (from 15 6 4% on day 5 to 17 6 3% at week 8, p 5
0.24), although by 8 weeks basal %S was no longer different
from that of normal subjects (19 6 3%, p 5 0.11).
When values from three transmural sites and all slices from
apex to base were averaged, significant improvement in %S
was seen in all regions around the short axis of the ventricle
between the two studies. Septal %S increased from 9 6 5% to
11 6 5% (p , 0.02), anterior %S from 7 6 5% to 10 6 6%
(p , 0.02), lateral %S from 16 6 6% to 19 6 5% (p , 0.01)
and inferior %S from 16 6 8% to 18 6 6% (p , 0.04). Only
the inferior wall demonstrated normal %S, both on day 5 and
at week 8 after MI.
Predictors of LV remodeling. Stepwise multivariate regres-
sion analysis for the change in LVEDVI from day 5 to week 8
after MI demonstrated that the only significant predictor was
peak creatine kinase (DLVEDVI 5 0.004 3 Peak creatine
kinase 1 1.30, p , 0.05, r 5 0.43). Lower %S at the LV base
on day 5 after MI showed a trend toward predicting a change
in LVEDVI (p 5 0.09). Variables that were not significantly
associated with an increase in LVEDVI were age (p 5 0.85),
male gender (p 5 0.28), time to reperfusion (p 5 0.75), ACE
inhibitor (p 5 0.59) or beta-blocker therapy (p 5 0.44), LVMI
(p 5 0.25), LVEDVI (p 5 0.22), LVESVI (p 5 0.99), apical
%S (p 5 0.92) and endocardial %S throughout the heart (p 5
0.66). No independent predictors of improvement in LVEF
from the day 5 to week 8 study were found.
Discussion
This study demonstrated that in the 8 weeks after a large
anterior MI in 26 patients with single-vessel LAD disease,
regional intramyocardial function improved within all of the
apical regions as well as the midanterior, midseptal and basal
lateral regions. Dysfunction in remote noninfarct-related re-
gions, including the midinferior and basal lateral regions (12),
resolved in the later post-MI period. Despite the improvement
in regional intramyocardial function, the LV dilated with a
mean increase in end-diastolic volume of 13 ml/m2, or 16%,
although global LV function improved with an increase in the
EF from 39 6 12% to 45 6 14%. The only significant predictor
of the increase in LVEDVI was peak creatine kinase as a
measure of infarct size. Percent S at the LV base on day 5, a
marker of remote region dysfunction, tended to predict in-
creased LVEDVI.
Previous animal studies. In an ovine model of nonreper-
fused anteroapical infarction, we found no improvement in
function within the infarct zone over a 6-month period, most
likely due to its transmural nature (7). Using radiopaque
markers in a pig model of infarction, Holmes et al. (18)
demonstrated an absence of systolic segment shortening in the
infarct zone 3 weeks after MI. In accordance with the present
study, our ovine study demonstrated a trend toward improve-
ment in %S from week 1 to week 8 after MI in adjacent and
remote noninfarct-related regions (7). Despite improved re-
gional function, LV dilation progressed in this model.
Previous human studies. Imaging modalities used previ-
ously to study LV remodeling (6,19,20) have not allowed
evaluation of intramyocardial function. However, Picard et al.
(19) demonstrated by two-dimensional echocardiography that
the amount of dysfunctional endocardial surface area indexed
to body size increases over a 3-month period after nonreper-
fused anterior MI, mostly due to infarct expansion at the apex.
These patients developed global LV dilation in an era before
the use of ACE inhibitors. Other investigators have shown
improvement in regional function in reperfused infarction with
echocardiographic techniques (21,22). Hirose et al. (23) dem-
onstrated by serial cine computed tomographic scanning after
MI that intrinsic LV contractile performance did not change as
estimated by a fall in the rate-corrected velocity of circumfer-
ential fiber shortening, which was termed an appropriate
response to increased LV end-systolic wall stress.
Using radionuclide angiography, Jeremy et al. (24) demon-
strated that of 50 patients with a first MI, 21 (42%) demon-
Figure 3. Percent circumferential intramyocardial shortening (%S) by
short-axis and long-axis locations in patients on day 5 (striped bars)
and at week 8 (solid bars) after anterior MI when values from all
transmural sites are averaged. A 5 anterior; I 5 inferior; L 5 lateral;
S 5 septal. *p , 0.05 versus day 5.
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strated an increase of end-diastolic volume by .20% over a
6-month period. Eight of these 21 patients dilated progres-
sively on serial examinations and all eight had anterior infarc-
tions. Serial cine computed tomographic scanning in patients
after the initial transmural anterior MI and in patients with
patent infarct-related arteries, before ACE inhibitors were
used routinely (25), has shown that the LV end-diastolic
volume increased 22%, from 148 6 8 to 180 6 9 ml during the
first year after MI, whereas LV mass tended to decrease in the
first 6 weeks, consistent with the present study. Approximately
40% of the increase in LV end-diastolic volume occurred in
the first 9 weeks. In mid-ventricular echocardiographic images
from the Survival and Ventricular Enlargement (SAVE) study,
the percent change in LV cavity area at 1 year was 27% in the
treated group and 29% in the nontreated groups (20). Another
study using quantitative echocardiography over the course of a
year after anterior and inferior MI (26) showed no increase in
end-systolic volumes and an improvement in LVEF, similar to
the findings of the present study.
Potential mechanisms. Several potential mechanisms may
explain improved function in the apex and midanterior and
midseptal regions. For one, these regions are heterogeneous,
likely representing a mix of infarct-related and adjacent
noninfarct-related tissue, and for that reason, demonstrate
some residual %S on day 5. The improvement may primarily
occur within islands of noninfarct-related myocardium adja-
cent to infarct-related myocardium (7). Improved %S may also
represent resolution of stunning (27) due in part to successful
reperfusion (21,22) and the effects of ACE inhibitors (20,28),
with which the majority of patients were treated. Resolution of
the dysfunction in remote noninfarct-related regions may be
due to a reduction in tethering effects as the mechanical
function of more apical regions improve, or to improvement in
blood flow reserve in these regions (29). Reduced end-systolic
wall stress (30) is an unlikely mechanism of improved function
as end-systolic volume and systolic blood pressure were un-
changed and LV mass tended to decrease.
Potential mechanisms for the continued increase in end-
diastolic volume despite improved regional function include
expansion of the infarct-related territory (2,3,18,19) and cell
slippage in infarct-related and noninfarct-related regions
(5,31). Elevated mechanical load has been postulated as a
stimulus to remodeling (6,7), as has neurohumoral stimulation,
which has been associated with increased cardiovascular mor-
tality and heart failure (32). ACE inhibition is known to limit
but not prevent increases in end-diastolic volume over time
(20,28).
Correlates of LV remodeling. A study by Gaudron et al.
(33) of 70 patients after their first MI identified several factors
by multivariate analysis that were predictors of remodeling
over a 3-year period. Predictors in their study included initial
LVEF and stroke index, ventriculographic infarct size, infarct
location (anterior) and TIMI flow grade infarct-related artery
perfusion. In the present study, all of the infarcts were anterior
and demonstrated Thrombolysis in Myocardial Infarction flow
grade 3. Peak creatine kinase, as a marker of infarct size, was
an important predictor. Apical %S, as a marker of infarct
region function, did not correlate with remodeling, likely due
to the uniformity of dysfunction within the infarct-related
region. Endocardial %S within the whole heart by magnetic
resonance tagging on day 5 was not predictive of remodeling
and may not correlate closely to absolute infarct size owing to
the presence of dysfunctional myocardium that later improves.
However, %S at the base on day 5, representative of dysfunc-
tion in regions remote from the infarct, tended to have
predictive value.
Studies in the rat model have demonstrated that the degree
of LV remodeling (34) and mortality after MI (14) are linearly
related to infarct size. Using technetium-99m sestamibi imag-
ing to define infarct size in humans, investigators at the Mayo
Clinic (35) showed a close correlation between infarct size and
changes over the first year after MI in end-systolic volume (r 5
0.63) and LVEF (r 5 20.66) in a patient group with a
documented patent infarct-related artery.
Study limitations. One limitation of the study is the size of
the study group. Certainly, a larger patient study group would
improve the power of the study to identify predictors of the
remodeling process. Nonetheless, the patient group is homo-
geneous (all had reperfused anterior MI with single-vessel
LAD disease) and MRI data on changes in LV volumes are
reproducible (36). The homogeneity of the patient group
precludes the extrapolation of these data to patients with
inferior infarction, previous infarction, multivessel disease or
nonreperfused infarction.
Ensuring that %S is measured in the same regions in the
two studies is a potential pitfall. However, this problem was
alleviated by measuring %S in each slice from apex to base and
dividing the ventricle into apical, mid and basal thirds. This
could lead to small potential errors in matching regions, in that
remodeling is characterized by lengthening of noninfarct-
related regions over time (6,7). However, the same number of
7-mm thick slices were imaged on the day 5 and week 8 studies
(n 5 12 6 1 vs. n 5 12 6 1, p 5 NS).
Values for %S may be heart rate–dependent over wide
ranges of changes. A modest fall in heart rate was noted
between the two studies (80 6 13 beats/min on day 5 vs. 73 6
17 beats/min at week 8 [p , 0.02]) and might explain part of
the improvement in %S over time. There were 11 patients
whose heart rate fell by .10 beats/min. However, there was no
significant difference between this group and the group of 15
patients whose heart rate did not fall by .10 beats/min in the
increase in %S from day 5 to week 8 averaged for the whole
heart (4 6 2% for those with a heart rate decrease .10
beats/min vs. 2 6 3% for the others, p 5 0.14).
The only significant predictor of change in LVEDVI over
time was peak creatine kinase as a reasonable estimate of
infarct size. Creatine kinase has been used for nearly three
decades for infarct sizing (37,38) but has known limitations in
the reperfusion era (39). All the patients in this study had
regional ventricular dysfunction at study entry and were reper-
fused on average .5 h after chest pain onset, which may
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enhance the ability to use peak creatine kinase as a measure of
infarct size.
The patients did not uniformly have assessment of the
patency of the infarct-related artery at the time of the 8-week
study, although all arteries were patent on day 5 and there
were no documented interval events in the study group. A
subgroup of 14 patients did have assessment of patency by
MRI coronary angiography (40), and of those, 13 had flow
visualized within the LAD. The beneficial effect of infarct-
related artery patency on LV remodeling and prognosis after
acute MI is now well established (41,42). Reocclusion without
reinfarction can lead to increased remodeling (43).
Types but not doses of medications were recorded at the
time of MRI at 8 weeks after MI. The doses of ACE inhibitors
and beta-blockers may have been increased slightly between
day 5 and hospital discharge. Recent data suggest that higher
doses of ACE inhibitors have more favorable effects on LV
size and function early after MI (44). Higher doses of ACE
inhibitors might have limited the increase in LVEDVI seen in
this study.
Conclusions. In the first 8 weeks after large reperfused first
anterior MI, intramyocardial function improved in the apex
and mid-anteroseptum, dysfunction resolved in remote
noninfarct-related regions and LVEF rose. However, LV
end-diastolic volumes increased despite improvement in func-
tion during this period. The increase in LVEDVI correlated
with infarct size by creatine kinase and was not related to
changes in global and regional LV function.
We gratefully acknowledge the patient recruitment efforts of Susan Petruolo,
RN, and the support of the magnetic resonance imaging technologists at
Allegheny General Hospital, especially June Yamrozik and Lois Miller.
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